Vaccines are not yet approved for use in the Australian pig industry. Trials are underway in Australia with a goal of local vaccine development and they are also evaluating the potential use of commercial vaccines from Japan. However, historical vaccines are based on protection against JEV genotype III and efficacy against genotype IV would require confirmation.
Dr. Schipp credited their work with wildlife organizations, including Wildlife Health Australia, as invaluable. Further, he emphasized a One Health collaboration as essential; in Australia, pre-existing data sharing arrangements with public health colleagues were vital to an effective response.
Australian Pork Producer Perspective
Drs. Kirsty Richards and Bernie Gleeson with SunPork, an Australian pork production company, reviewed their experiences and learnings as well during the symposium.
The initial indications of JEV on sow farms included delayed farrowing, reduced litter size, increased return to service, late term abortions, mummified, stillborn and shaking piglets. Case studies of four affected Sun Pork herds demonstrated up to a 9% decrease in pigs weaned.
Substantial production and financial costs have occurred due to JEV and an estimated 60% of Australia's pork industry has been impacted, with a reduction of fresh pork supply from August-November this year.
There were parallel responses in the animal and human sectors with mosquito trapping and testing being conducted for surveillance early in the outbreak. Mosquito trapping varied significantly across SunPork farms, with 50,000 to 100,000 trapped at one location and just four at another.
Risk factors included standing water volume, water birds, and mosquitoes. The SunPork veterinarians said Australia is still working to identify how many bird species are competent hosts for JEV and the extent to which these interact with piggery operations. There is also uncertainty about the mosquito quantity that is needed to trigger an outbreak. Importantly, their experience showed that pig and semen movement was not a significant contributor to JEV spread.
Australian Surveillance Pivots to JEV
David Williams, lead, Diagnosis and Mammalian Infectious Disease Research Group, and colleagues at the Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, were heavily involved in the laboratory diagnosis of JEV infections of animals throughout the 2022 outbreak.
In addition to human and domestic pig cases detected after the initial 2022 outbreak, active infections were detected in over 50 feral pigs in the Northern Territory of Australia. Several suspected horse cases as well as a single alpaca case were reported.
A One Health approach was undertaken to understand the molecular epidemiology of the Genotype IV outbreak strain of JEV, involving public and animal health laboratories from each of the affected Australian states. Whole genome sequences of JEV were contributed from infected domestic and feral pigs, humans and mosquitoes for phylogenetic analyses, which showed no clear geographic, temporal or host relationships between isolates. The data also supported pig movements as unlikely to have played a role in transmission.
Diagnostic testing at the Australia Centre for Disease Preparedness included the initial case confirmation from February 25, 2022, and resulted in genome characterization. Following the primary diagnosis, confirmatory testing and surveillance were launched.
Click here to see more...